By Dr Diana Schuhmacher

Journal articles

Bergsma P; Porazinski S; Istadi A; Chacon-Fajardo D; Mahmood Y; Lombardi S; Schuhmacher D; Barraclough-Franks H; Strbenac D; Dennis CV; Faizi-Sobbi P; Cahill E; Bhadri VA; De Almeida Silva J; Lum T; Wykes J; Manzie T; Palme CE; Yang JYH; Clark JR; Gupta R; Pajic M, 2025, 'Integration of whole genome sequencing analysis with unique patient-derived models reveals clinically relevant drug targets in TFCP2 fusion-defined rhabdomyosarcoma.', Mol Cancer Ther, http://dx.doi.org/10.1158/1535-7163.MCT-24-0704

Back to profile page